Comparison 28. Subgroup analysis: Response at early phase [1‐4 weeks]‐Outpatient.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Milancipran vs SSRIs	2	372	Risk Ratio (M‐H, Random, 95% CI)	1.06 [0.73, 1.52]
1.1 Milnacipran vs Fluoxetine	1	70	Risk Ratio (M‐H, Random, 95% CI)	1.06 [0.41, 2.73]
1.2 Milnacipran vs Paroxetine	1	302	Risk Ratio (M‐H, Random, 95% CI)	1.05 [0.71, 1.56]